VISTAGEN THERAPEUTICS INC (VTGN)       0.1709  +0.01 (+8.3%)

0.1709  +0.01 (+8.3%)

US92840H2022 - Common Stock - After market: 0.17 0 (-0.53%)

2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
2019
(2019-3-31)
2018
(2018-3-31)
Revenue
1.11M1.09M0.000.000.00
Non Recurring Items
N/AN/A0.00-20.00K-140.00K
Gross Profit
1.11M1.09MN/AN/AN/A
Operating Expenses
48.89M19.02M20.80M24.56M14.19M
Operating Income
-47.78M-17.93MN/AN/AN/A
Interest Expense
19.90K1.60K30.00K-10.00K-10.00K
Income Before Taxes
-47.76M-17.93M-20.77M-24.59M-14.34M
Income Tax
3.40K2.60K0.000.000.00
Net Income
-47.76M-17.93M-20.77M-24.59M-14.35M
EBITDA
-47.62M-17.82MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.24-0.21-0.47-0.86-1.03
Non GAAP EPS
-0.25-0.39-0.50-0.91-0.83
 
Statistics
Gross Profit Margin
100.10%100.05%N/AN/AN/A
Operating Profit Margin
-4308.58%-1646.01%N/AN/AN/A

All data in USD

Charts